Search Videos and More
News
Patient Undergoes Milestone 2nd High-Intensity Focused Ultrasound (HiFU) for Essential Tremor
HiFU offers an incisionless outpatient procedure for patients with essential tremor or Parkinson’s disease who don’t get acceptable tremor relief from medications.
Video
Low-Intensity Focused Ultrasound (LIFU) for Non-Small Cell Lung Cancer Brain Metastases
Presenter
Manmeet Ahluwalia, M.D., MBA, FASCO
News
Gallbladder Cancer: Progress and Hope for Future Breakthroughs
For Gallbladder Cancer Awareness Month, Horacio J. Asbun, MD, and Domenech Asbun, MD, shared their thoughts and strategies for treating patients with this disease from the surgical and clinical sides.
Presenter
Nish Patel, M.D.
Presenter
Tom C. Nguyen, M.D.
News
McGinn Family Tradition: Inspiring the Next Generation of Coronary Bypass Surgeons
The old adage that the apple doesn’t fall far from the tree is certainly true in the McGinn family.
News
Study: Ablative Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy May Improve Overall Survival in Patients with Pancreatic Cancer
A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve local control (LC) and overall survival (OS) in patients with borderline resectable (BRPC) and locally advanced pancreas cancer (LAPC).
News
When Your Patient Needs an Oral Medicine Evaluation
Whether your patient is being treated for cancer, has an autoimmune disease or an inflammatory condition that is causing an oral problem apart from the teeth and gums, they may benefit from an evaluation and treatment by an oral medicine specialist.
Presenter
Rachel V F Rohaidy, M.D.
News
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial
Baptist Health Miami Cancer Institute is leading a groundbreaking clinical trial that is studying the use of a new medication combined with stereotactic radiosurgery to combat metastatic brain cancer.
News
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors
Researchers from Miami Cancer Institute, part of Baptist Health South Florida, recently published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.